Custom service
AI-based Peptide Drug Discovery and Structure Analysis Platform
Apply structure prediction and ai screening to peptide discovery programmes
The service is built around structure-prediction guided screening. Depending on the molecule we may move to ML-based activity scoring or in-silico triage before synthesis to improve stability, loading or yield, and every batch is released with ranked candidates with modeling rationale.
Because AI-based Peptide Drug Discovery and Structure Analysis Platform projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Reducing synthesis burden on large candidate sets
Prioritizing analogs for synthesis
Programmes expecting AI to replace binding assays
Targets with no assayable readout and no purified protein available
Screening programmes close with a data package: primary screen statistics, confirmation data for each hit, counterscreen results and resynthesized material. Library lots ship with composition QC — representation and identity checks by LC-MS or NGS as the format requires.
Service Highlights
- Structure-prediction guided screening as the default route, with ML-based activity scoring held as a proven fallback
- In-silico triage before synthesis worked into the design where the application requires it
- Every reported hit is confirmed by independent resynthesis and re-testing before it reaches you
- Analytical confirmation of every intermediate before the final release
- Library integrity (composition, representation) is measured, not assumed, before screening begins
- Ranked candidates with modeling rationale delivered with a complete conjugation or synthesis certificate
How the work runs
Library design
Diversity, degeneracy and deconvolution strategy for AI-based Peptide Drug Discovery and Structure Analysis Platform are fixed in a design document.
Library synthesis or construction
The library is built with structure-prediction guided screening and its composition is QC'd before screening.
Primary screening
Screening runs with ML-based activity scoring, with controls and statistics defined in advance.
Hit deconvolution
Hits are identified and ranked; counterscreens remove non-specific and promiscuous binders.
Hit confirmation
Every hit is resynthesized and re-tested; only reproducible hits advance.
Hit delivery
Confirmed hits and Ranked candidates with modeling rationale are delivered with the full screening data package.
Specifications & timeline
- Turnaround
- 4–8 weeks
- Typical scale
- 10^2 – 10^9 members by format
- Chemistry options
- structure-prediction guided screening; ML-based activity scoring; in-silico triage before synthesis
- Deliverable
- Ranked candidates with modeling rationale
- QC package
- Library composition QC, screening raw data, hit confirmation package
- Shipping
- Ambient (plates, beads) or dry ice (display libraries)
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.